+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Interleukin-12 Expression Stimulants - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-12 Expression Stimulants - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Complement C3 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C3 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Integrin Alpha4beta1 Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Integrin Alpha4beta1 Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Sigma-1 Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Sigma-1 Receptor Agonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
ROS1 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

ROS1 Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Nociceptin Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Nociceptin Receptor Agonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Trk (TrkB) Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Trk (TrkB) Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
ACE/ARB Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

ACE/ARB Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
PD-1 And PD-L1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

PD-1 And PD-L1 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 200 Pages
  • Global
From
Angiotensin Type 1 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Angiotensin Type 1 Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin 6 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin 6 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Alpha 1 Adrenergic Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha 1 Adrenergic Receptor Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HAVCR2 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

HAVCR2 Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Immunoglobulin Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Immunoglobulin Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Amyloid Precursor Protein Secretase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Amyloid Precursor Protein Secretase Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Iron Deficiency Anemia - Pipeline Insight, 2025 - Product Thumbnail Image

Iron Deficiency Anemia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Nerve Growth Factor Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Nerve Growth Factor Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Tau Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Tau Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Sodium-glucose Transporter 2 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Sodium-glucose Transporter 2 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more